Skip to main content
BXC
NYSE Trade & Services

Shareholders Approve 9.5% Potential Dilution for Equity Plan; Board Overrules Vote to Retain Director

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Consumer
Sentiment info
Negative
Importance info
8
Price
$46.86
Mkt Cap
$364.683M
52W Low
$44.78
52W High
$88.3
52W Position info
4.6% above low
Off High info
47% below high
Rel. Volume info
1.3× avg
Market data snapshot near publication time

BXC is trading near its 52-week low of $44.78 (4.6% above the low).

Summary

BlueLinx shareholders approved a significant increase in shares for an equity incentive plan, while the Board controversially retained a director who failed to win re-election.


Key Events · Corporate Governance and Compliance · BXC

  • Significant Potential Dilution Approved

    Shareholders approved an amendment to the 2021 Long-Term Incentive Plan, increasing the number of shares reserved for issuance by 750,000. This represents a potential dilution of approximately 9.5% based on current outstanding shares.

  • Board Overrules Shareholder Vote on Director

    Director Mitchell B. Lewis failed to receive a majority of votes for re-election at the Annual Meeting. Despite tendering his resignation, the Board unanimously rejected it, citing his qualifications and experience, and he will remain a director.

  • Nominating Committee Leadership Change

    Mr. Lewis will be replaced as Chairman of the Nominating Committee by Marietta Edmunds Zakas, following proxy advisor recommendations against his re-election due to non-independence concerns.


Analysis · BXC · Trade & Services

Shareholders approved a significant increase of 750,000 shares for the company's long-term incentive plan, representing a potential dilution of approximately 9.5% if all shares are issued. This comes as the company is trading near its 52-week lows and recently reported a net loss for Q1 2026. Additionally, the Board of Directors unanimously rejected the resignation of Mr. Lewis, who failed to receive a majority of votes for re-election from shareholders, raising governance concerns about the Board's responsiveness to shareholder sentiment.

How filings like this one have moved

In the 30 days to Nov 6, 2026, 44.9% of the 1407 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.36%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BXC was trading at $46.86 on NYSE in the Trade & Services sector, with a market capitalization of approximately $364.7M. The 52-week trading range was $44.78 to $88.30. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BXC - Latest Insights

BXC
Nov 03, 2026, 4:11 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $72.56
Real-time Price: $66.44 info
Change: -$6.12 (-8%) info
Market Cap: $522.521M info
BXC
Nov 03, 2026, 4:05 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $72.56
Real-time Price: $66.44 info
Change: -$6.12 (-8%) info
Market Cap: $522.521M info
BXC
Aug 04, 2026, 4:25 PM EDT
Source: Reuters
Importance Score:
8
Price at Filing: $68.47
Real-time Price: $66.44 info
Change: -$2.03 (-3%) info
Market Cap: $522.521M info
BXC
Aug 04, 2026, 4:18 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $69.00
Real-time Price: $66.44 info
Change: -$2.56 (-4%) info
Market Cap: $522.521M info
BXC
Aug 04, 2026, 4:14 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $69.00
Real-time Price: $66.44 info
Change: -$2.56 (-4%) info
Market Cap: $522.521M info